Gyre Therapeutics Plunges 10.08% Amid Technical Sell Signals

On April 9, 2025, Gyre Therapeutics experienced a significant drop of 10.08% in pre-market trading, marking a notable decline in its stock price.

Gyre Therapeutics has seen substantial volatility in recent trading sessions. On April 8, 2025, the stock price fell by 4.99%, closing at $7.24 after fluctuating between a day low of $7.06 and a day high of $8.85. This volatility is part of a broader trend that has seen the stock lose 23.71% over the past two weeks.

The company's stock has been under pressure due to negative signals from various technical indicators. The long-term moving average holds a general sell signal, while the short-term moving average indicates a buy signal. This mixed signal suggests a cautious outlook for the stock. Additionally, the 3-month Moving Average Convergence Divergence (MACD) is currently issuing a sell signal, further complicating the near-term prospects.

Despite the recent decline, Gyre Therapeutics has shown resilience in the face of market volatility. The stock has support at $7.09, which could act as a buying opportunity if tested. However, the high volatility and wide prediction interval from the Bollinger Band indicate that the stock is considered "very high risk."